B-Disease	0	8	Birdshot
I-Disease	9	26	chorioretinopathy
O	26	27	:
O	28	32	long
O	32	33	-
O	33	37	term
O	38	52	manifestations
O	53	56	and
O	57	63	visual
O	64	73	prognosis
O	73	74	.

O	76	78	To
O	79	88	ascertain
O	89	92	the
O	93	101	clinical
O	102	110	features
O	111	114	and
O	115	119	long
O	119	120	-
O	120	124	term
O	125	131	visual
O	132	141	prognosis
O	142	144	of
B-Disease	145	153	birdshot
I-Disease	154	171	chorioretinopathy
O	172	173	(
B-Disease	173	176	BCR
O	176	177	)
O	177	178	,
O	179	182	and
O	183	185	to
O	186	194	identify
O	195	203	patients
O	204	206	at
O	207	211	risk
O	212	214	of
B-Symptom	215	221	visual
I-Symptom	222	226	loss
O	226	227	.

O	228	241	Retrospective
O	242	256	noncomparative
O	257	261	case
O	262	268	series
O	268	269	.

O	270	275	Fifty
O	275	276	-
O	276	280	five
O	281	292	consecutive
O	293	301	patients
O	302	306	with
B-Characteristic	307	310	HLA
I-Characteristic	310	311	-
I-Characteristic	311	314	A29
I-Characteristic	314	315	-
I-Characteristic	315	323	positive
B-Disease	324	327	BCR
O	328	331	who
O	332	336	were
O	337	347	identified
O	348	350	in
O	351	364	ophthalmology
O	365	376	departments
O	377	379	of
O	380	383	the
O	384	394	University
O	395	402	Medical
O	403	409	Center
O	410	412	of
O	413	420	Utrecht
O	421	424	and
O	425	428	The
B-Anatomy	429	432	Eye
O	433	441	Hospital
O	442	451	Rotterdam
O	451	452	,
O	453	455	of
O	456	460	whom
O	461	463	37
O	464	468	were
O	469	477	observed
O	478	481	for
O	482	484	at
O	485	490	least
O	491	492	5
O	493	498	years
O	498	499	.

O	500	501	A
O	502	508	review
O	509	511	of
O	512	515	the
O	516	523	medical
O	524	527	and
B-Diagnostic_tool	528	540	photographic
I-Diagnostic_tool	541	544	and
I-Diagnostic_tool	544	545	/
I-Diagnostic_tool	545	547	or
I-Diagnostic_tool	548	560	angiographic
I-Diagnostic_tool	561	568	records
O	569	571	of
O	572	574	55
O	575	583	patients
O	584	588	with
B-Characteristic	589	592	HLA
I-Characteristic	592	593	-
I-Characteristic	593	596	A29
I-Characteristic	596	597	-
I-Characteristic	597	605	positive
B-Disease	606	609	BCR
O	609	610	.

O	611	619	Numerous
O	620	629	variables
O	630	634	were
O	635	643	compared
O	643	644	,
O	645	654	including
O	655	658	age
O	659	662	and
O	663	669	gender
O	670	682	distribution
O	682	683	,
O	684	689	onset
O	690	693	and
O	694	700	course
O	701	703	of
B-Disease	704	707	BCR
O	707	708	,
O	709	715	ocular
O	716	730	manifestations
O	730	731	,
O	732	743	therapeutic
O	744	754	strategies
O	755	758	and
O	759	764	their
O	765	773	outcomes
O	773	774	,
O	775	788	complications
O	788	789	,
O	790	798	systemic
O	799	807	diseases
O	807	808	,
B-Characteristic	809	815	visual
I-Characteristic	816	822	acuity
O	823	824	(
B-Characteristic	824	826	VA
O	826	827	)
O	827	828	,
O	829	832	and
O	833	841	features
O	842	852	associated
O	853	857	with
O	858	862	poor
O	863	869	visual
O	870	877	outcome
O	877	878	.

B-Symptom	879	883	Loss
I-Symptom	884	886	of
I-Symptom	887	889	VA
O	890	893	was
O	894	901	gradual
O	901	902	;
O	903	906	the
O	907	913	number
O	914	916	of
O	917	925	affected
B-Anatomy	926	930	eyes
O	931	935	with
B-Symptom	936	938	VA
I-Symptom	939	943	less
I-Symptom	944	948	than
I-Symptom	949	951	20
I-Symptom	951	952	/
I-Symptom	952	955	200
O	956	965	increased
O	966	970	from
O	971	972	9
O	973	975	of
O	976	979	108
O	980	981	(
O	981	982	8
O	982	983	%
O	983	984	)
O	985	987	at
O	988	993	onset
O	994	996	to
O	997	999	22
O	1000	1002	of
O	1003	1005	73
O	1006	1007	(
O	1007	1009	30
O	1009	1010	%
O	1010	1011	)
O	1012	1014	at
O	1015	1016	5
O	1017	1022	years
O	1023	1026	and
O	1027	1029	19
O	1030	1032	of
O	1033	1035	49
O	1036	1037	(
O	1037	1039	39
O	1039	1040	%
O	1040	1041	)
O	1042	1044	at
O	1045	1047	10
O	1048	1053	years
O	1054	1056	of
O	1057	1063	follow
O	1063	1064	-
O	1064	1066	up
O	1066	1067	.

O	1068	1071	The
O	1072	1077	cause
O	1078	1080	of
B-Symptom	1081	1092	compromised
I-Symptom	1093	1095	VA
O	1096	1099	was
O	1100	1113	predominantly
B-Symptom	1114	1121	macular
I-Symptom	1122	1127	edema
O	1128	1131	and
B-Symptom	1132	1139	macular
I-Symptom	1140	1147	atrophy
O	1148	1149	(
O	1149	1151	42
O	1152	1154	of
O	1155	1157	55
O	1158	1159	[
O	1159	1161	76
O	1161	1162	%
O	1163	1165	of
O	1166	1171	cases
O	1171	1172	]
O	1172	1173	)
O	1173	1174	.

O	1175	1177	We
O	1178	1183	found
O	1184	1190	strong
O	1191	1203	associations
O	1204	1211	between
O	1212	1215	the
B-Characteristic	1216	1218	VA
O	1219	1221	at
B-Disease	1222	1227	onset
O	1228	1231	and
B-Symptom	1232	1238	visual
I-Symptom	1239	1246	outcome
I-Symptom	1247	1252	after
I-Symptom	1253	1254	5
I-Symptom	1255	1258	and
I-Symptom	1259	1261	10
I-Symptom	1262	1267	years
O	1268	1269	(
O	1269	1270	P
O	1271	1272	=
O	1273	1274	0
O	1274	1275	.
O	1275	1278	005
O	1279	1282	and
O	1283	1284	P
O	1285	1286	=
O	1287	1288	0
O	1288	1289	.
O	1289	1292	006
O	1292	1293	,
O	1294	1306	respectively
O	1306	1307	)
O	1307	1308	.

B-Characteristic	1309	1313	Mean
I-Characteristic	1314	1316	VA
I-Characteristic	1317	1319	at
I-Characteristic	1320	1323	the
I-Characteristic	1324	1325	5
I-Characteristic	1325	1326	-
I-Characteristic	1326	1330	year
I-Characteristic	1331	1337	follow
I-Characteristic	1337	1338	-
I-Characteristic	1338	1340	up
I-Characteristic	1341	1344	was
I-Characteristic	1345	1358	significantly
I-Characteristic	1359	1364	lower
O	1365	1367	if
B-Symptom	1368	1375	macular
I-Symptom	1376	1383	leakage
O	1384	1387	was
O	1388	1396	observed
O	1397	1399	on
B-Diagnostic_tool	1400	1411	angiography
O	1412	1413	(
O	1413	1414	P
O	1415	1416	<
O	1417	1418	0
O	1418	1419	.
O	1419	1422	001
O	1422	1423	)
O	1423	1424	.

O	1425	1427	No
O	1428	1439	differences
O	1440	1442	in
O	1443	1449	annual
B-Symptom	1450	1454	loss
I-Symptom	1455	1457	of
I-Symptom	1458	1460	VA
O	1461	1465	were
O	1466	1474	observed
O	1475	1482	between
O	1483	1491	patients
O	1492	1499	treated
O	1500	1502	by
O	1503	1511	standard
O	1512	1523	therapeutic
O	1524	1534	modalities
O	1535	1538	and
O	1539	1548	untreated
O	1549	1557	patients
O	1557	1558	.

O	1559	1562	The
O	1563	1569	visual
O	1570	1579	prognosis
O	1580	1582	of
B-Disease	1583	1586	BCR
O	1587	1589	in
O	1590	1591	a
O	1592	1600	spectrum
O	1601	1603	of
B-Disease	1604	1611	uveitis
O	1612	1614	is
O	1615	1619	poor
O	1619	1620	,
O	1621	1624	and
O	1625	1628	the
O	1629	1640	recommended
O	1641	1652	therapeutic
O	1653	1661	regimens
O	1662	1666	have
O	1667	1670	had
O	1671	1673	no
O	1674	1680	effect
O	1681	1683	on
O	1684	1688	long
O	1688	1689	-
O	1689	1693	term
O	1694	1700	visual
O	1701	1710	prognosis
O	1710	1711	.

O	1712	1715	New
O	1716	1725	treatment
O	1726	1736	strategies
O	1737	1740	are
O	1741	1747	needed
O	1748	1751	for
O	1752	1756	this
B-Disease	1757	1765	blinding
I-Disease	1766	1774	disorder
O	1774	1775	.
